334 related articles for article (PubMed ID: 22260523)
1. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
2. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
[TBL] [Abstract][Full Text] [Related]
3. Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2.
Tan S; Ding K; Li R; Zhang W; Li G; Kong X; Qian P; Lobie PE; Zhu T
Breast Cancer Res; 2014 Apr; 16(2):R40. PubMed ID: 24735615
[TBL] [Abstract][Full Text] [Related]
4. Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells.
Wickramasinghe NS; Manavalan TT; Dougherty SM; Riggs KA; Li Y; Klinge CM
Nucleic Acids Res; 2009 May; 37(8):2584-95. PubMed ID: 19264808
[TBL] [Abstract][Full Text] [Related]
5. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
6. An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma.
Masuda M; Miki Y; Hata S; Takagi K; Sakurai M; Ono K; Suzuki K; Yang Y; Abe E; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
J Transl Med; 2012 Sep; 10 Suppl 1(Suppl 1):S2. PubMed ID: 23227519
[TBL] [Abstract][Full Text] [Related]
7. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
8. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
9. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G; Lacroix-Triki M; Pierredon S; Gratadou L; Schmidt S; Bénès V; Roché H; Dalenc F; Auboeuf D; Millevoi S; Vagner S
Cancer Res; 2009 Nov; 69(21):8332-40. PubMed ID: 19826037
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
Di Leva G; Gasparini P; Piovan C; Ngankeu A; Garofalo M; Taccioli C; Iorio MV; Li M; Volinia S; Alder H; Nakamura T; Nuovo G; Liu Y; Nephew KP; Croce CM
J Natl Cancer Inst; 2010 May; 102(10):706-21. PubMed ID: 20388878
[TBL] [Abstract][Full Text] [Related]
11. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
12. 17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells.
Zhang C; Zhao J; Deng H
Mol Cell Biochem; 2013 Jul; 379(1-2):201-11. PubMed ID: 23568502
[TBL] [Abstract][Full Text] [Related]
13. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
14. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
Munagala R; Aqil F; Vadhanam MV; Gupta RC
Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3/BCl-2/survivin pathway.
Wang X; Qiu W; Zhang G; Xu S; Gao Q; Yang Z
Int J Clin Exp Pathol; 2015; 8(5):5017-25. PubMed ID: 26191195
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
18. Effect miR-214-3p on proliferation and apoptosis of breast cancer cells by targeting survivin protein.
Han LC; Wang H; Niu FL; Yan JY; Cai HF
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7469-7474. PubMed ID: 31539134
[TBL] [Abstract][Full Text] [Related]
19. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α.
Ali HO; Arroyo AB; González-Conejero R; Stavik B; Iversen N; Sandset PM; Martínez C; Skretting G
J Thromb Haemost; 2016 Jun; 14(6):1226-37. PubMed ID: 26999003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
